Market Access Views & Analysis

Views & Analysis

Market Access

Nine for 2023, part three: thriving or surviving?

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry

Sales & Marketing

Experts share tips for training MSLs in a world that needs t...

Medical Science Liaisons (MSLs) have an important role to play in today’s health ecosystem.

Market Access

Crossed wires? Mixed messages on medicines

Leela Barham argues that the latest operational guidance for the NHS in England continues to illustrate a disconnect between the messages in big-ticket policy documents from the central gov

Market Access

Nine for 2023, part one: a reflection on inflection

The Roman god Janus, as we are frequently reminded in January, was two faced and able to look forward to the coming year and backward to reflect on the past one.

Market Access

Upholding regulatory compliance in decentralised trials

Before getting lost in the vast options a decentralised clinical trial (DCT) setup provides, sponsors considering a DCT model need to keep in mind that it is not a one-size-fits-all approac

Pharma Market Access